Skip to main content

Table 2 Comparison of all patients before and after treatment

From: Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis

Parameter Before After
BMI (kg/m2) n = 30 23.0 ± 0.8 23.0 ± 0.8
Systolic blood pressure (mmHg) n = 31 150.0 ± 5.0 159.4 ± 4.2
Diastolic blood pressure (mmHg) n = 31 73.1 ± 3.0 76.3 ± 2.6
Total protein (g/dL) 6.5 ± 0.1 6.6 ± 0.1
Albumin (g/dL) n = 34 3.7 ± 0.1 3.8 ± 0.1
AST (U/L) 15.1 ± 0.8 13.4 ± 0.8*
ALT (U/L) n = 34 12.0 ± 1.0 10.1 ± 1.1
γGTP (U/L) 22.5 ± 2.5 23.4 ± 4.2
Total bilirubin (mg/dL) n = 29 0.35 ± 0.02 0.28 ± 0.02*
ALP (U/L) n = 34 257.4 ± 23.6 265.1 ± 22.0
LDH (U/L) n = 34 189.6 ± 5.9 183.3 ± 5.7
BUN (mg/dL) 54.7 ± 1.7 54.0 ± 2.0
Creatinine (mg/dL) 8.27 ± 0.32 8.32 ± 0.38
Total cholesterol 159.0 ± 6.0 155.5 ± 5.4
LDL-C (mg/dL) n = 34 83.1 ± 4.1 80.3 ± 3.8
HDL-C (mg/dL) 47.1 ± 2.8 48.8 ± 2.9
Triglyceride (mg/dL) n = 33 120.7 ± 7.7 124.4 ± 8.9
GA (%) 21.9 ± 0.6 22.7 ± 0.9
CPR (ng/mL) n = 32 9.39 ± 0.89 10.73 ± 0.94*
BG (mg/dL) 167.0 ± 7.1 162.7 ± 6.9
BNP (ng/mL) n = 32 405.5 ± 88.6 410.4 ± 90.8
oxLDL (U/L) n = 33 98.4 ± 5.1 91.6 ± 5.2
hsCRP (mg/dL) n = 30 0.204 ± 0.056 0.187 ± 0.056
8OHdG (ng/mL) n = 17 0.344 ± 0.021 0.338 ± 0.031
  1. * P < 0.05 compared with before treatment